May 09, 2007 09:26 ET

Emerging Equity Alert for Wednesday, May 09, 2007: LDPH New Consulting Agreement With NanoBioDesign Ltd!

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Peter Antipatis of Capital Research Group Inc.

WESTON, FL--(Marketwire - May 9, 2007) - Announces the following stocks to its Breaking News List: London & Pacific Healthcare, Inc. (PINKSHEETS: LDPH), Sonus Networks, Inc. (NASDAQ: SONS), Powerwave Technologies, Inc. (NASDAQ: PWAV), DOR BioPharma, Inc. (OTCBB: DORB).

London & Pacific Healthcare, Inc. (PINKSHEETS: LDPH), a corporate finance and development company working with a select group of healthcare enterprises, just announced that it has executed an agreement with NanoBioDesign, Ltd. of the United Kingdom. The Company will assist NBD in attracting investment capital from India.

Executive Chairman and CEO Stuart Bruck said, "We are pleased to have this chance to work with an exciting young company like NanoBioDesign. There are many companies in the Indian market looking to establish linkages with innovative companies in the Western markets, and London & Pacific can serve as an excellent bridge to these new relationships."

London & Pacific Healthcare, Inc., with offices in Los Angeles and London, operates three synergistic operating divisions that capitalize on emerging growth opportunities in the global healthcare industry. Its London-based division City & Westminster Advisers Limited provides comprehensive strategic and financial advisory services to healthcare start-ups, small and mid-sized organizations. Its two California-based divisions, HealthSPAC LLC, acts as an incubator for Special Purpose Acquisition Companies (SPACs), and Healthcare Fund Advisors LLC, provides specialized buy-side sourcing and analysis services to clients that invest in the global healthcare sector. For additional information, please visit the corporate website at

Other stocks highlighted include Sonus Networks, Inc. (NASDAQ: SONS): Hot Stocks List, up 5% on 13 million shares, Powerwave Technologies, Inc. (NASDAQ: PWAV): Hot Stocks List, down 4% on 10 million shares, DOR BioPharma, Inc. (OTCBB: DORB): Hot Stocks List, down 7% on 7 million shares.'s Daily Stock Updates:, a leader in corporate communications and finance, highlights stocks that are in the news, have traded high volume, or experienced a large change in price in recent sessions. The aforementioned commentary is not meant to be indicative of a "long term" view of any of the companies listed. For more go to Daily Ranking is consistently ranked in the top 4 on the "Best performing promoters of all time" list. This is out of over 1,000 promoters and promotional campaigns tracked by Visit for more details.

All material herein was prepared by CRG Partners, Inc. (CRGP) based upon information believed to be reliable. The information contained herein is not guaranteed by CRGP to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. CRGP is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. CRGP has been compensated by third party shareholders with shares or with cash from the company on behalf of one or more of the companies mentioned in this opinion. CRGP has been compensated one hundred fifty thousand shares for LDPH. CRGP has also purchased fifteen thousand shares in the open market. CRGP intends to sell its shares. CRGP has sold approximately zero LDPH shares to date. CRGP may sell its shares for less than the target price given in this opinion. In addition to any compensation mentioned above, additional compensation can be equal to ten percent of any newly issued or registered securities of the profiled companies. CRGP and its web site are operated under a license from Capital Research Group, Inc., Inc. and One Source Solutions Inc. (Licensors) and CRGP is not the agent of any of the Licensors and CRGP is solely responsible for all statements made herein. CRGP's affiliates, officers, directors and employees intend to buy and sell additional shares in any company mentioned herein and may profit in the event those shares rise in value. CRGP will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

Contact Information